Excerpted and adapted from:
Yalamanchili P, Lee LY, Bushnell G, et al. Trends in new use of disease-modifying antirheumatic drugs for juvenile idiopathic arthritis among commercially insured children in the United States from 2001 to 2022. Arthritis Rheumatol. 2025 Apr;77(4):468–476.